Cerestat NMDA: Began a safety and dose-escalation trial

Cambridge Neuroscience Inc. (CNSI), Cambridge, Mass. Product: Cerestat NMDA channel blocker that prevents glutamate-induced influx of calcium into neurons Indication: Traumatic brain injury Status: Be...